Understanding the intricate mechanisms by which UBE2T regulates p53 could unveil new therapeutic targets and strategies for cancer treatment, particularly in overcoming drug resistance and enhancing the effectiveness of cancer therapies. This evidence concerns the gene TP53 and cancer.